A trial of the tolerability and pharmacodynamics of an intranasal formulation of midazolam in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2015
At a glance
- Drugs Midazolam (Primary) ; Midazolam (Primary)
- Indications Epilepsy; Seizures
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 24 Nov 2015 Results will be presented at the 69th Annual Meeting of the American Epilepsy Society (AES), according to an Upsher-Smith media release.
- 02 Sep 2015 Results published in the Epilepsia.
- 23 Jun 2013 Results presented at the 30th International Epilepsy Congress.